-
Medical journals
- Career
Prevention of Bacterial Endocarditis in Patients with Prosthetic Valve
Authors: V. Vinduška
Authors‘ workplace: Klinika kardiovaskulární a transplantační chirurgie IKEM, Praha
Published in: Čas. Lék. čes. 1999; : 82-83
Category:
Overview
American Heart Association published in 1997 new version of recommendations for prevention of bacterialendocarditis in risk patients. Postoperative stadium in patients with prosthetic valve belongs to the highest risk.Infection can develop during bacteremia, which occurs most frequently at stomatologic and urologic interventions.The whole scale of medical interventions can be covered by two universal antibiotical regimes - one for the mouth,respiratory and upper GI tract, second for urogenital and lower GI tract. In the first case 2 g of Amoxiciline areadministered p.o. 2 hours before the intervention. Interventions are individually listed, and cases where antibioticalprophylaxis is not recommended are separately given. Special situations are discussed.
Key words:
bacterial endocarditis, prosthetic valve, antibiotical prophylaxis.
Labels
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain management Dental Hygienist
Article was published inJournal of Czech Physicians
-
All articles in this issue
- Health Needs Assessment. Part 2. Need for Health and Need for Health Care
- Endocrinology 1999–2000
- Genetic Predisposition for Multiple Metabolic Syndrome. Part. 2. Candidate Genes for TypeII Diabetes Mellitus
- Skin Explant Assay – an in vitro Graft versus Host Disease PredictiveTest for Allogeneic Haematopoietic Stem Cell Transplantation
- Molecular Genetic Analysis of Alzheimer’s Disease in the Czech Population.Mutation (APP-717) in the Gene for the Amyloid Precursor Protein (APP)
- Budesonide (Turbuhaler), 400 mg/day, is at Least as Effective as a DoubleDose of Beclomethasone (MDI) in Patients with Mild to Medium Severe Bronchial Asthma
- Common Polymorphisms in the Cholesterol Ester Transfer Protein,Apolipoprotein CIII and Lipoprotein Lipase Genes in High- and Low-Cholesterolemic Children
- Prevention of Bacterial Endocarditis in Patients with Prosthetic Valve
- Talc - Standard Medicament in the Treatment of Malignant Pleural Effusion
- Return of Czech Health Professionals to Most in Spring 1945
- On the Use of Publications and Documents of WHO
- Development of European Medicine up to Vesalius (16th century)
- Effects of Hormonal Replacement Therapy on the Cardiovascular System
- Journal of Czech Physicians
- Journal archive
- Current issue
- Online only
- About the journal
Most read in this issue- Talc - Standard Medicament in the Treatment of Malignant Pleural Effusion
- Budesonide (Turbuhaler), 400 mg/day, is at Least as Effective as a DoubleDose of Beclomethasone (MDI) in Patients with Mild to Medium Severe Bronchial Asthma
- Health Needs Assessment. Part 2. Need for Health and Need for Health Care
- Development of European Medicine up to Vesalius (16th century)
Login#ADS_BOTTOM_SCRIPTS#Forgotten passwordEnter the email address that you registered with. We will send you instructions on how to set a new password.
- Career